Finance
The funds will be used to accelerate the expansion of its digital care platform for respiratory health.
The company is planning to list the initial stock price somewhere between $20 and $23 per share.
The acquired company, which focuses on the hair-loss space, caters to the U.K. market.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
The Copenhagen-based startup will use funds to help more health and fitness coaches build online businesses.
This addition is expected to help CareDx expand into the medication adherence space.
The acquisition will support Carbon Health’s primary care model, which combines in-person clinics with a virtual care platform.
The company plans to use this M&A to gain a foothold in the Medicare space.
The global health service company has launched a region-specific offering aimed at “SMEs, corporates and government organisations” within the country.
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.